Trials and Performance
GLP-1 medications have become an increasingly popular solution for peoples weight loss woes
Your doctor can help you decide
Free radicals are unstable molecules that form in response to factors like your diet and the environment
In a phase 2, randomized, double-blind, placebo-controlled trial (NCT05669599) of adults with obesity (with and without type 2 diabetes), once-monthly MariTide produced dose-dependent reductions in body weight of up to 16% at 52 weeks, compared with approximately 2% to 3% with placebo
She says sometimes people question why she's on the drug, "because they look at me and think I'm at healthy weight, or maybe they even think I'm thin." What people don't see is Woodard's previous struggles with obesity, which began in her 30s, and landed her at 260 pounds